miR-107对卵巢癌细胞免疫逃逸的调控和紫杉醇耐药性的影响

doi:10.13481/j.1671-587X.20220323

Abstract

Abstract:

Objective： To investigate the effect of microRNA-107（miR-107）on the taxol （TAX）-resistance in the ovarian cancer cells by regulating immune escape through the mitogen-activated protein 3 kinase 7 （MAP3K7），and to charify its mechanism.

Methods

The 293T cells were divided into miR-NC group（transfected with miR-NC） and miR-107 mimics group（transfected with miR-107 mimics）.The ovarian cancer SKOV3 cells were treated with concentration gradient increasing method to obtain the TAX resistant SKOV3/TAX cells. The SKOV3/TAX cells were randomly divided into blank control group， TAX （given 4.0 μmol·L^－1 TAX） group， TAX+miR-107 mimics （given 4.0 μmol·L^－1 TAX and transfected with miR-107 mimics） group，TAX+miR-107 mimics+pcDNA-MAP3K7 （given 4.0 μ mol·L^－1 TAX and transfected with miR-107 mimics and pcDNA-MAP3K7）， and co-cultured with the human peripheral blood lymphocytes HPBL， respectively. Then they were divided into HPBL group， HPBL+SKOV3/TAX group， HPBL+ SKOV3/TAX+TAX group， HPBL + SKOV3/TAX+TAX+miR-107 mimics group and HPBL+ SKOV3/TAX+TAX+miR-107 mimics+pcDNA-MAP3K7 group. The expression levels of miR-107 in the cells in various groups were detected by real-time fluorescence quantitative PCR （RT-qPCR）method， the targeting relationship between miR-107 and MAP3K7 was verified by double luciferase reporter gene experiment， the expression levels of MAP3K7 and FAS proteins in the cells in various groups were detected by Western blotting method， the survival rates of the cells in various groups were detected by CCK-8 method， and the apoptotic rates of the cells in various groups were detected by flow cytometry.

Results

Compared with the human ovarian epithelial cells HOSEpic， the expression level of miR-107 in the ovarian cancer cells was decreased （P<0.05）. There was a targeted binding site between 3′-UTR of MAP3K7 and miR-107. The double luciferase reporter gene experiment results showed that compared with miR-NC group， the luciferase activity of wild-type MAP3K7 in miR-107 over-expression group was decreased （P<0.01）. The Western blotting results showed that the expression level of MAP3K7 protein in the cells in miR-107 over-expression group was significantly lower than that in miR-NC group （P<0.01）. The RT-qPCR results showed that compared with blank control group， the expression level of miR-107 mRNA in the SKOV3/TAX cells in TAX group was increased（P<0.01）； compared with TAX group， the expression level of miR-107 mRNA in the SKOV3/TAX cells in miR-107 MICs+TAX group was increased（P<0.05）. Compared with blank control group， the expression levels of MAP3K7 and FAS proteins in the SKOV3 / TAX cells in TAX group were decreased （P<0.01）； compared with TAX group， the expression levels of MAP3K7 and FAS proteins in the cells in TAX+miR-107 mimics SKOV3/TAX group were decreased （P<0.05 or P<0.01）； compared with TAX+miR-107 mimics group， the expression levels of MAP3K7 and FAS proteins in the SKOV3/TAX cells in TAX+miR-107 mimics+pcDNA-MAP3K7 group were increased（P<0.05 or P<0.01）.Compared with HPBL+SKOV3/TAX group， the expression level of FAS protein and apoptotic rate of the HPBL cells in HPBL+SKOV3/TAX+TAX group were decreased （P<0.05）； compared with HPBL+SKOV3/TAX+TAX group， the expression level of FAS protein and the apoptotic rate in the HPBL cells in HPBL+SKOV3/TAX+TAX + miR-107 mimics group were decreased（P<0.05）； compared with HPBL+SKOV3/TAX+TAX+miR-107 mimics group， the expression level of FAS protein in the HPBL cells in HPBL+SKOV3/TAX+TAX+miR-107 mimics+pcDNA-MAP3K7 group was decreased （P<0.01）， and the apoptotic rate was decreased （P<0.01）. Compared with blank control group， the survival rate of the SKOV3/TAX cells in TAX group was decreased （P<0.05）；compared with TAX group，the survival rate of the SKOV3/TAX cells in TAX+miR-107 mimics group was significantly decreased（P<0.05）. Compared with TAX + miR-107 mimics group， the survival rate of the SKOV3/TAX cells in TAX+miR-107 mimics+pcDNA-MAP3K7 group was increased （P<0.05）. The apoptotic rate of the SKOV3/TAX cells in TAX group was significantly higher than that in blank control group （P<0.05）， the apoptotic rate of the SKOV3/TAX cells in TAX+miR-107 group was significantly higher than that in TAX group （P<0.05）， and the apoptotic rate of the cells in TAX+miR-107 mimics+pcDNA-MAP3K7 group was lower than that in TAX+miR-107 mimics group （P<0.05）.

Conclusion

MiR-107 is low-expressed in the SKOV3/TAX cells， and over-expression of miR-107 could inhibit the immune escape of the SKOV3/TAX cells and alleviate the TAX resistance of the ovarian cancer cells by inhibiting the expression of MAP3K7.

Key words: Ovarian neoplasm, MicroRNA-107, Immune escape, Taxol, Drug resistance

CLC Number:

R737.31

Qinghui WANG,Bo LI,Chuancui HU,Mingchao NIE,Xiaomei ZHENG. Effects of miR-107 on regulation of immune escape and taxol resistance of ovarian cancer cells[J].Journal of Jilin University(Medicine Edition), 2022, 48(3): 734-743.

Figures/Tables 12

Fig.1

Fig.2

Fig.3

Tab.1

Tab. 2

Fig. 4

Tab. 3

Fig.5

Fig. 6

Tab. 4

Fig. 7

Tab. 5

References 28

1	STEWART C， RALYEA C， LOCKWOOD S. Ovarian cancer： an integrated review［J］. Semin Oncol Nurs， 2019， 35（2）： 151-156.
2	MCMULLEN M， KARAKASIS K， MADARIAGA A， et al. Overcoming platinum and PARP-inhibitor resistance in ovarian cancer［J］. Cancers， 2020， 12（6）： 1607.
3	LAU T S， CHAN L K Y， MAN G C W， et al. Paclitaxel induces immunogenic cell death in ovarian cancer via TLR4/IKK₂/SNARE-dependent exocytosis［J］.Cancer Immunol Res，2020，8（8）： 1099-1111.
4	WOLF D， FIEGL H， ZEIMET A G， et al. High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome［J］. Int J Cancer， 2020， 146（7）： 2007-2018.
5	DIECKMANN K P， RADTKE A， GECZI L， et al. Serum levels of microRNA-371a-3p （M371 test） as a new biomarker of testicular germ cell tumors： results of a prospective multicentric study［J］. J Clin Oncol， 2019， 37（16）： 1412-1423.
6	XIONG Y Q， LIU Z M， LI Z， et al. Long non‑coding RNA nuclear paraspeckle assembly transcript 1 interacts with microRNA‑107 to modulate breast cancer growth and metastasis by targeting carnitine palmitoyltransferase‑1［J］. Int J Oncol， 2019， 55（5）： 1125-1136.
7	CHEN H A， LI C C， LIN Y J， et al. Hsa-miR-107 regulates chemosensitivity and inhibits tumor growth in hepatocellular carcinoma cells［J］. Aging， 2021， 13（8）： 12046-12057.
8	SU H W， TAO T， YANG Z， et al. Circular RNA cTFRC acts as the sponge of microRNA-107 to promote bladder carcinoma progression［J］. Mol Cancer， 2019， 18（1）： 27.
9	TANG Z H， FANG Y X， DU R. microRNA-107 induces cell cycle arrests by directly targeting cyclin E1 in ovarian cancer［J］. Biochem Biophys Res Commun， 2019， 512（2）： 331-337.
10	LHEUREUX S， BRAUNSTEIN M， OZA A M. Epithelial ovarian cancer： evolution of management in the era of precision medicine［J］. CA Cancer J Clin， 2019， 69（4）： 280-304.
11	UPADHYAY R， BOIARSKY J A， PANTSULAIA G， et al. A critical role for fas-mediated off-target tumor killing in T-cell immunotherapy［J］. Cancer Discov， 2021， 11（3）： 599-613.
12	YAMADA A， ARAKAKI R， SAITO M， et al. Dual role of fas/FasL-mediated signal in peripheral immune tolerance［J］. Front Immunol， 2017， 8： 403.
13	PARDOLL D M. The blockade of immune checkpoints in cancer immunotherapy［J］. Nat Rev Cancer， 2012， 12（4）： 252-264.
14	IQBAL M A， ARORA S， PRAKASAM G， et al. MicroRNA in lung cancer： role， mechanisms， pathways and therapeutic relevance［J］. Mol Aspects Med， 2019， 70： 3-20.
15	PERRIER A， DIDELOT A， LAURENT-PUIG P，et al.Epigenetic mechanisms of resistance to immune checkpoint inhibitors［J］. Biomolecules， 2020， 10（7）： 1061.
16	FUJITA Y， YAGISHITA S， HAGIWARA K， et al. The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer［J］. Mol Ther， 2015， 23（4）： 717-727.
17	NEVIANI P， WISE P M， MURTADHA M， et al. Natural killer-derived exosomal miR-186 inhibits neuroblastoma growth and immune escape mechanisms［J］. Cancer Res， 2019， 79（6）： 1151-1164.
18	JIN D， GUO J W， WU Y， et al. M 6 A demethylase ALKBH₅ inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC［J］. Mol Cancer， 2020， 19（1）： 40.
19	WEI J， XU H F， WEI W， et al. circHIPK₃ promotes cell proliferation and migration of gastric cancer by sponging miR-107 and regulating BDNF expression［J］. Onco Targets Ther， 2020， 13： 1613-1624.
20	TIAN X H， WU Y Y， YANG Y T， et al. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling［J］. Mol Oncol， 2020， 14（2）： 462-483.
21	FU Y X， LIN L W， XIA L G. miR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1［J］. Cell Mol Biol Lett， 2019， 24： 31.
22	WEI X Q， LEI Y J， LI M J， et al. miR-107 inhibited malignant biological behavior of non-small cell lung cancer cells by regulating the STK33/ERK signaling pathway in vivo and vitro ［J］.J Thorac Dis， 2020，12（4）： 1540-1551.
23	CORDAS DOS SANTOS D M， EILERS J， SOSA VIZCAINO A， et al. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB［J］. BMC Cancer， 2018， 18（1）： 663.
24	LE GOFF C， ROGERS C， LE GOFF W， et al. Heterozygous mutations in MAP3K7， encoding TGF-β-activated kinase 1， cause cardiospondylocarpofacial syndrome［J］. Am J Hum Genet， 2016，99（2）： 407-413.
25	ZHOU L L， DONG J L， HUANG G， et al. microRNA-143 inhibits cell growth by targeting ERK5 and MAP3K7 in breast cancer［J］. Braz J Med Biol Res， 2017， 50（8）： e5891.
26	FAN H， GE Y G， MA X， et al. Long non-coding RNA CCDC144NL-AS1 sponges miR-143-3p and regulates MAP3K7 by acting as a competing endogenous RNA in gastric cancer［J］. Cell Death Dis， 2020， 11（7）： 521.
27	ZEHAVI L， SCHAYEK H， JACOB-HIRSCH J， et al. miR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma［J］. Mol Cancer， 2015， 14： 68.
28	JIN X， DING D L， YAN Y Q， et al. Phosphorylated RB promotes cancer immunity by inhibiting NF-κB activation and PD-L1 expression［J］. Mol Cell， 2019， 73（1）： 22-35.e6.

Group	Survival rate
TAX (μmol·L^－1)
0	99.21±0.48
1	84.29±2.78
2	65.07±3.54
3	52.86±3.09
4	44.93±3.29
5	32.52±3.11

Group	Expression level of miR-107 mRNA
Blank control	99.21±0.48
TAX	84.29±2.78^*
TAX+miR-107 mimics	65.07±3.54^△
TAX+miR-107 mimics+pcDNA-MAP3K7	52.86±3.09

Group	Expression level of MAP3K7	Expression level of FAS
Blank control	1.01±0.12	1.00±0.07
TAX	0.56±0.10^*	0.74±0.08^*
TAX+miR-107 mimics	0.25±0.07^△	0.30±0.06^△△
TAX+miR-107 mimics+pcDNA-MAP3K7	0.68±0.05^#	0.59±0.10^#

Group	Expression level of FAS	Apoptotic rate(η/%)
HPBL	1.02±0.11	6.24±1.77
HPBL+SKOV3/TAX	2.58±0.30^*	30.45±4.98^*
HPBL+SKOV3/TAX+TAX	1.95±0.19^△	20.33±2.95^△△
HPBL+SKOV3/TAX+TAX+miR-107 mimics	1.54±0.10^#	11.15±2.18^#
HPBL+SKOV3/TAX+TAX+miR-107 mimics+ pcDNA-MAP3K7	2.04±0.19^○	21.00±3.00^○

Group	Survival rate	Apoptotic rate
Blank control	1.95±0.22	11.01±2.17
TAX	1.56±0.08^*	17.43±1.68^**
TAX+miR-107 mimics	1.07±0.17^△	26.42±3.03^△
TAX+miR-107 mimics+pcDNA-MAP3K7	1.47±0.12^#	20.51±0.95^#

Effects of miR-107 on regulation of immune escape and taxol resistance of ovarian cancer cells

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 12

References 28

Related Articles 15

Metrics

Comments

Recommended 0

[1]	Shunjia SONG,Xinying WANG,Feifei JIANG,Huijian JIA,Yuan ZHAO,Zhiping YANG,Liyuan SUN,Yundong ZHAO. Resistance rates of Helicobacter pylori to clarithromycin, metronidazole, and levofloxacin and mutation characteristics of their related drug resistance genes [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 630-637.
[2]	Lisong CHEN,Hui FANG,Hefei WANG,Chengyuan HE,Xiaodong GAI,Chun LI. Effects of Notch1 signaling pathway on invasion and cisplatin resistance of lung adenocarcinoma cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2021, 47(5): 1171-1177.
[3]	Jingjing GE,Hongxia XU,Lixia XIE,Kaili DU,Ming SANG,Xiaodong SUN. Establishment of human serous ovarian cancer cell culture system in vitro and its application in chemotherapeutic drug sensitivity detection [J]. Journal of Jilin University(Medicine Edition), 2021, 47(4): 999-1007.
[4]	Xiulan YE, Ming LI, Zhaojian WANG, Haiyan ZHAO, Jianning MA, Jing LIU, Yi ZHENG, Shunqing LI, Yu ZHANG. Effects of Cornus officinalis polysaccharide on behavior and multidrug resistance gene 1b and major vault protein expressions in hippocampus tissue of refractory epilepsy young rats [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 644-651.
[5]	Aihua REN,Wan LIU,Dawei WANG. Influence of PD-L1 knockout based on CRISPR/Cas9 technology in gefitinib resistance sensitivity of PC-9/T790M in non-small cell lung cancer [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 292-298.
[6]	Guo HUANG,Youquan WANG,Juan CHEN. Reverse effect of miR-138-5p targeted inhibition of HIF-1α expression on cisplatin resistance of breast cancer MCF-7 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 360-368.
[7]	Guang YAO,Yuying LU,Qinghua ZHANG,Haixia ZHU,Yiwei CHEN,Dong SUN,Zhen ZHUANG,Feng ZHANG,Ding LIU,Zhi SONG. Genomic evolution and drug resistance analysis of human-derived Listeria monocytogenes [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 180-186.
[8]	GUO Xiaofei, LIU Lihong, AI Hao. Expression of valosin-containing protein in epithelial ovarian cancer tissue and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 600-606.
[9]	REN Aihua, WANG Dawei. Effect of CRISPR/Cas9-mediated TKI on sensitivity of non-small cell lung cancer gene targeting gefitinib resistance and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1288-1293.
[10]	WANG Yipin, HE Dongyun, HUANG Qiongwei, SHENG Minjia. Application value of risk ovarian malignancy algorithm in early diagnosis of epithelial ovarian cancer [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 905-910.
[11]	PEI Yanling, LYU Hanghang, WANG Bowei, ZHANG Weiyang. Misdiagnosis of ovarian fibrothecoma as ovarian malignant tumor: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 940-943.
[12]	LIANG Bing, LIU Yang, SONG Jinping, QU Danhua, LIU Chunyan. Enhancement of histone deacetylase inhibitors SAHA in chemotherapeutic sensitivity of ovarian cancer SKOV3 cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 471-476.
[13]	SHANGGUAN Mengyuan, ZHAO Jing, YANG Yanrong, ZHANG Jiayue, CHEN Junyu, ZHAO Shuhua. Inhibitory effects of gomisin A combined with carboplatin on proliferation,invasion and metastasis of human ovarian cancer Skov3 cells and their mechanisms [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 292-298.
[14]	ZHONG Lili, ZHAO Yinlong, LI Bingjin, ZOU Xiaohan, CHENG Ziqian, CUI Ranji. Effects of MicroRNA-210 on growth and radiosensitivity of ovarian cancer cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 265-269.
[15]	YANG Li, WANG Xuewen, ZHOU Ming, ZHANG Fan. Effect of arsenic trioxide combined with γ-secretase inhibitor MW167 on drug resistance of human hepatocellular carcinoma HepG₂/ADM cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 1-7.